BioSpace News Archive

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, announced that the Company will have two oral presentations at the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting to be held November 9-11, 2018 in Washington, D.C.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today presented preclinical results that support the potential of CTP-692, the Company’s novel drug candidate for schizophrenia, to improve the safety profile of D-serine. CTP-692 is a deuterated form of D-serine, an endogenous co-agonist of the N-methyl-D-aspartate (NMDA) receptor.

First and Only Positive Phase 3 Study in Third- and Fourth-Line RCC

The Data Institute (DI) at the University of San Francisco (USF) is thrilled to announce the launch of the Wicklow AI and Medical Research Initiative (WAMRI), a new research lab focusing on the development of practical applications of AI in medicine.

On Friday, November 2, 2018, an important settlement was reached between Stryker Corp., the manufacturer of the Stryker LIFT V40 hip replacement implant, and Appointed Leadership Counsel on behalf of some Plaintiffs with lawsuits pending in both federal and state courts.

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, applauds today’s announcement by the Government of Mexico establishing guidelines for the sanitary control of cannabis and its extracts.

Universal light modulator may soon be a game-changer for photonics applications that require high power

Ameda Breastfeeding Products today announced its launch of Finesse™ - a personal breast pump inspired by their hospital technology.

Tata Consultancy Services, (TCS), (BSE: 532540, NSE: TCS) a leading IT services, consulting and business solutions organization, has donated 5,000 pro bono technical and scientific research hours to Seattle Children’s Center for Integrative Brain Research (Seattle Children’s), in a collaborative effort to discover the causes of Sudden Unexpected Infant Deaths (SUID), which includes Sudden Infant Death Syndrome (SIDS).

William L. Oppenheim, M.D., director of the Cerebral Palsy Program at Orthopaedic Institute for Children (OIC) and director of the UCLA/Orthopaedic Hospital Center for Cerebral Palsy, has been named the 2018 recipient of the Distinguished Service Award of the Section of Orthopaedic Surgery of the American Academy of Pediatrics.